$7.99 +0.11 (1.37%)

Verastem, Inc. (VSTM)

Verastem, Inc. (VSTM) is a biotechnology company focused on developing and commercializing medicines for cancer treatment. The company emphasizes targeting cancer stem cells to improve therapy outcomes, with a portfolio that includes drugs aimed at Kuren and other oncology indications. Founded in 2010, Verastem aims to advance innovative approaches to solid tumor and hematologic cancers.

🚫 Verastem, Inc. does not pay dividends

Company News

High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds
Benzinga • Prnewswire • July 23, 2025

Despite regulatory challenges and budget cuts, the oncology market is projected to reach US$900 billion by 2034, with several biotech companies advancing innovative cancer therapies and demonstrating promising clinical trial results.

Verastem, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire
GlobeNewswire Inc. • N/A • July 10, 2024

The Portnoy Law Firm has initiated an investigation into Verastem, Inc. (NASDAQ: VSTM) for potential securities fraud after the company disclosed serious adverse events in a clinical trial, causing a significant drop in its stock price.

Verastem: A Shocking Drop On 'Positive' Data (Maintain Buy)
Seeking Alpha • Galzus Research • May 26, 2024

Verastem Oncology is on track to secure a drug approval for avutometinib, but their low cash position poses a significant risk. Find out why VSTM stock is a Buy.

Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data
Zacks Investment Research • Zacks Equity Research • May 24, 2024

Verastem (VSTM) gains 57% post-market on achieving a confirmed partial response in 83% of first-line patients treated with novel combo therapy in the initial cohort of its phase I/II pancreatic cancer study.

Trading Penny Stocks This Week? 3 Mistakes to Avoid
PennyStocks • D. Marie • May 30, 2023

Avoid these mistakes when you're trading penny stocks The post Trading Penny Stocks This Week? 3 Mistakes to Avoid appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.